دورية أكاديمية

Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in spontaneously hypertensive rats

التفاصيل البيبلوغرافية
العنوان: Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in spontaneously hypertensive rats
المؤلفون: Malwina M. Roszkowska-Chojecka, Iwona Baranowska, Olga Gawrys, Janusz Sadowski, Agnieszka Walkowska, Malgorzata Kalisz, Anna Litwiniuk, Elzbieta Kompanowska-Jezierska
المصدر: Clinical and Experimental Hypertension, Vol 43, Iss 5, Pp 392-401 (2021)
بيانات النشر: Taylor & Francis Group, 2021.
سنة النشر: 2021
المجموعة: LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية: chymase, chymostatin, hypertension, renin-angiotensin system, angiotensin ii, spontaneously hypertensive rats, renal blood flow, Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: Background: Chymase generates angiotensin II (ANG II) independently of angiotensin-converting enzyme in tissues and it contributes to vascular remodeling and development of hypertension, however the exact mechanism of its action is unclear. Methods: Hence, the effects of chymase inhibition were examined in anesthetized spontaneously hypertensive rats (SHR) in two stages of the disease development, ie. pre-hypertensive (SHR7) and with established hypertension (SHR16). Chymostatin, a commercial chymase inhibitor, was infused intravenously alone or in subsequent groups co-infused with captopril. Results: Mean blood pressure (MBP), total renal blood flow (RBF) and ANG II content (plasma and tissues) were measured. In SHR16 chymase blockade significantly decreased MBP (−6%) and plasma (−38%), kidney (−71%) and heart (−52%) ANG II levels. In SHR7 chymostatin did not influence MBP or RBF, but significantly decreased heart ANG II level. Conclusion: Jointly, functional studies and ANG II determinations support the evidence that in SHR chymase can raise plasma ANG II and contribute to blood pressure elevation. We propose that addition of chymase blockade to ACE inhibition could be a promising approach in the treatment of hypertensive patients resistant to therapy with ACE-inhibitors alone.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1064-1963
1525-6006
10641963
Relation: https://doaj.org/toc/1064-1963; https://doaj.org/toc/1525-6006
DOI: 10.1080/10641963.2021.1890762
URL الوصول: https://doaj.org/article/fc2203001dc649d7a2ed576dc376bf11
رقم الأكسشن: edsdoj.fc2203001dc649d7a2ed576dc376bf11
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:10641963
15256006
DOI:10.1080/10641963.2021.1890762